Biography/Memoir

Roadman Investments to attend Europe’s largest psychedelic conference

Roadman’s dedicated Health and Wellness committee… anticipates that its attendance of the conference [Breaking Convention 2019] will result in increased visibility to a plethora of potential alpha generating deal flow within this burgeoning vertical. Original Article (Yahoo Finance):Roadman Investments to attend Europe’s largest psychedelic conferenceArtwork Fair Use: shannonpatrick17

READ MORE
Biography/Memoir

[…synthetic psilocybin nose-spray]

Michael Hartman… has developed extensive metered-dose inhaler IP in the pharmaceutical world… before developing his pressurized (using 134A Freon) metered-dose inhaler IP (patent pending) through his company… [He states he] is keenly familiar with the fears that many have with using plant-based medicine. [His team is dedicated to] strive to have products in place that…

READ MORE
Biography/Memoir

People are hungry for [psilocybin mushroom reform].

As [Kevin] Matthews [successful campaign manager of Decriminalize Denver, which decriminalized psilocybin mushrooms in the City in May of 2019] put it, echoing a common sentiment among advocates and activists in the psychedelic space, “The cat’s out of the bag.” Unlike cannabis, it should be noted, decriminalizing psilocybin and other psychedelics doesn’t necessarily have to…

READ MORE
Biography/Memoir

Why a federally licensed marijuana researcher is suing the DEA

…claims that the DEA has created a monopoly around federally licensed marijuana research. …[Dr. Sue Sisley’s] concerned that her study’s results may have been compromised by poor cannabis quality, explaining that the marijuana is far less potent than strains available in dispensaries or on the black market; the limited strains from Mississippi are also mixed…

READ MORE
Biography/Memoir

The trip of a lifetime: women across the country are self-treating their depression and anxiety with mushrooms

Just as the majority of the country [in particular the women featured in this article] has begun to embrace medical and recreational marijuana, though, the tide may be shifting for psilocybin-containing mushrooms. 1. Amy Jackman, co-owner of a cannabis consulting business in Alaska, isn’t waiting around for a scientific seal of approval. She takes a…

READ MORE
Biography/Memoir

…psychedelic activists… after decrim wins

Jag Davies, a drug policy consultant with many years of experience in psychedelic policy at Drug Policy Alliance and MAPS, told Filter that decriminalization of psychedelics is a small step towards ensuring the safety—and legal rights—of people who use drugs in general.  The organizers behind both the Denver and Oakland initiatives have publicly stated that they hope these efforts can…

READ MORE
Biography/Memoir

Prescription opioid overdoses drop, as fentanyl deaths skyrocket

“It’s important that the public and policymakers recognize that the addiction crisis is unfortunately still alive and well. It’s just shifting.” – Adam Leventhal, director of the University of Southern California’s Institute for Addiction Science. Fentanyl, a powerful synthetic opioid often sold as a street drug, surpassed prescription opioids in 2015 as the most lethal overdose…

READ MORE
Biography/Memoir

DEA… a psychedelic plant, and a controversy… at Miami University

“Instead of placing arbitrary restrictions on conservatory holdings, we should be making sure that conservatories are sensibly and knowledgeably curated,” Executive Director of the American Anthropological Assiciation, Ed Liebow said. Since it’s not feasible for every researcher to travel to West Africa, Liebow said the most suitable approach was to establish conservatories where key specimens…

READ MORE
Biography/Memoir

Wuhan [China] signs letter of intent with Biodelta [South Africa] one month after launching psilocybin division

Although the psilocybin industry is still in its nascent stages, all signs suggest that the momentum behind developing psychedelic medicines will continue to grow.  As James Hamblin recently wrote in The Atlantic, “The growth of cannabis is a reminder that once there is money to be made, industries form lobbies in Washington, D.C., and it becomes…

READ MORE